🇬🇧 Limited Time — UK Only·🎓 Free Learning for 1 Month·🤖 Free AI Training Included·📚 4,000+ Lessons · 35,000+ Quizzes·🏆 GCSE Mocks · Olympiad Papers·⚡ Selected Students Only · Limited Places·🎁 Free Value Worth £2,000·🇬🇧 Limited Time — UK Only·🎓 Free Learning for 1 Month·🤖 Free AI Training Included·📚 4,000+ Lessons · 35,000+ Quizzes·🏆 GCSE Mocks · Olympiad Papers·⚡ Selected Students Only · Limited Places·🎁 Free Value Worth £2,000·🇬🇧 Limited Time — UK Only·🎓 Free Learning for 1 Month·🤖 Free AI Training Included·📚 4,000+ Lessons · 35,000+ Quizzes·🏆 GCSE Mocks · Olympiad Papers·⚡ Selected Students Only · Limited Places·🎁 Free Value Worth £2,000·
Back to questions directory
A-Level BiologyYear 2021Q2

Turn over 5 2 Acetylcholinesterase is an enzyme involved in regulating the transmission of nerve impulses across some synapses. (a) Acetylcholinesterase is found on the cell surface membranes of neurones and red blood cells. These acetylcholinesterase molecules have different primary structures. In humans, a single gene codes for acetylcholinesterase. (i) Explain how a single gene can give rise to acetylcholinesterase molecules with different primary structures. (2) .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... (ii) Explain how the acetylcholinesterase gene can be expressed in some tissues but not others. (3) .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... 6 (b) Alzheimer’s disease is associated with the loss of neurones that produce acetylcholine. It has been suggested that inhibitors of acetylcholinesterase may be useful in the treatment of Alzheimer’s disease. (i) Explain why inhibitors of acetylcholinesterase could be useful in the treatment of Alzheimer’s disease. (3) .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... Turn over 7 (ii) Trials of a new inhibitor were carried out using tissue cultures. The effect of the concentration of the inhibitor on acetylcholinesterase activity and cell viability was measured. Percentage cell viability was measured as the percentage of cells that were not killed by the inhibitor. The graph shows the results for this inhibitor. Acetylcholinesterase activity / a.u. Percentage cell viability (%) Concentration of inhibitor / µmol dm−3 Key Cell viability Acetylcholinesterase activity 4 3 2 1 0 250 200 0 50 150 100 100 75 50 25 0 State and justify a suitable concentration of inhibitor to use in clinical trials. (3) .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... .................................................................................................................................................................................................................................................................................... (Total for Question 2 = 11 marks)

Paper Source:9BN0_03_que_20211020.pdf

Get full Socratic AI guidance on this question — free in the Applaa desktop app

Appy Buddy guides you step-by-step toward the answer without giving it away. Type your attempt and get instant, mark-scheme-aware clues that teach you to think like an examiner.

Download Applaa Free →
Applaa Desktop App

Join Applaa Community

Create your own games, learn AI concepts, program interactive apps, and share with a kid-safe community approved by parents. Free forever on Windows and Mac.

Download Free

Available for Windows and macOS · COPPA Compliant

Exam Specification Info

This question is part of the UK A-Level Biology syllabus. In the actual exam, structured questions typically require linking specific keywords to gain full marks. Applaa helps you drill these topics.

Syllabus levelAdvanced Level (A-Level)
SubjectBiology
Official MarksVariable (2–6 marks)